A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The transforming genes of oncogenic retroviruses are homologous to a group of evolutionary conserved cellular onc genes. The human cellular homologue (c-abl) of the transforming sequence of Abelson murine leukaemia virus (A-MuL V) was recently shown to be located on chromosome 9. The long arm of this chromosome is involved in a specific translocation with chromosome 22, the Philadelphia translocation (Ph1), t(9; 22) (q34, q11), which occurs in patients with chronic myelocytic leukaemia (CML)3-5. Here we investigate whether the c-abl gene is included in this translocation. Using c-abl and v-abl hybridization probes on blots of somatic cell hybrids, positive hybridization is found when the 22q- (the Philadelphia chromosome), and not the 9q+ derivative of the translocation, is present in the cell hybrids. From this we conclude that in CML, c-abl sequences are translocated from chromosome 9 to chromosome 22q-. This finding is a direct demonstration of a reciprocal exchange between the two chromosomes and suggests a role for the c-abl gene in the generation of CML.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The importance of proto-oncogenes was further highlighted by discoveries that nonviral cancers frequently have genetic alterations in proto-oncogenes that activate them and drive oncogenesis—for example, mutations in H-ras or K-ras (76), gene amplification of c-myc (77), and chromosomal translocation/activation involving c-abl (78).”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [78]
Citations
Cites
ROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene
Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 944
Der, C. J., Krontiris, T. G., & Cooper, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3637 · Cited by 800
A physical map of the DNA regions flanking the rabbit β-globin gene
Jeffreys, A. (1977) · Cell · doi:10.1016/0092-8674(77)90119-2 · Cited by 644
Santos, E., Tronick, S. R., Aaronson, S. A., Pulciani, S., & Barbacid, M. (1982) · Nature · doi:10.1038/298343a0 · Cited by 623
Chang, E. H., Furth, M. E., Scolnick, E. M., & Lowy, D. R. (1982) · Nature · doi:10.1038/297479a0 · Cited by 587
Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosine
Witte, O. N., Dasgupta, A., & Baltimore, D. (1980) · Nature · doi:10.1038/283826a0 · Cited by 530
Goff, S. P., Gilboa, E., Witte, O. N., & Baltimore, D. (1980) · Cell · doi:10.1016/0092-8674(80)90554-1 · Cited by 470
Khan, P. M. (1971) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(71)80007-3 · Cited by 344
Chromosomal localization of human cellular homologues of two viral oncogenes
Heisterkamp, N., Groffen, J., Stephenson, J. R., Spurr, N. K., Goodfellow, P. N., Solomon, E., Carritt, B., & Bodmer, W. F. (1982) · Nature · doi:10.1038/299747a0 · Cited by 303
Self-citation
Research works printed but not linked: 2
- Heisterkamp, N., Groffen, J. & Stephenson, J. R. J. molec. appl. Genet. (in the press).
- Ferguson-Smith, M. A. & Aitken, D. A. Cytogenet. Cell Genet. 22, 49–451 (1978).
Cited by
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Burnside, R. D. (2015) · Cytogenetic and Genome Research · doi:10.1159/000438708 · Cited by 1,946
Cools, J., DeAngelo, D. J., Gotlib, J., Stover, E. H., Legare, R. D., Cortes, J., Kutok, J., Clark, J., Galinsky, I., Griffin, J. D., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025217 · Cited by 1,718
Fused transcript of abl and bcr genes in chronic myelogenous leukaemia
Shtivelman, E., Lifshitz, B., Gale, R. P., & Canaani, E. (1985) · Nature · doi:10.1038/315550a0 · Cited by 1,611
Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22
GROFFEN, J., STEPHENSON, J., HEISTERKAMP, N., DEKLEIN, A., BARTRAM, C., & GROSVELD, G. (1984) · Cell · doi:10.1016/0092-8674(84)90077-1 · Cited by 1,599
Self-citationReflecting on 25 years with MYC
Meyer, N., & Penn, L. Z. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2231 · Cited by 1,575
Gabert, J., Beillard, E., van der Velden, V. H. J., Bi, W., Grimwade, D., Pallisgaard, N., Barbany, G., Cazzaniga, G., Cayuela, J. M., Cavé, H., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403135 · Cited by 1,284
Chromosomal translocations in human cancer
Rabbitts, T. H. (1994) · Nature · doi:10.1038/372143a0 · Cited by 1,503
Baccarani, M., Cortes, J., Pane, F., Niederwieser, D., Saglio, G., Apperley, J., Cervantes, F., Deininger, M., Gratwohl, A., Guilhot, F., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.0779 · Cited by 1,291
Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene Products
Lugo, T. G., Pendergast, A.-M., Muller, A. J., & Witte, O. N. (1990) · Science · doi:10.1126/science.2408149 · Cited by 1,281
Chromosomal stability and the DNA double-stranded break connection
van Gent, D. C., Hoeijmakers, J. H. J., & Kanaar, R. (2001) · Nature Reviews Genetics · doi:10.1038/35056049 · Cited by 1,219
Cleary, M. L., Smith, S. D., & Sklar, J. (1986) · Cell · doi:10.1016/0092-8674(86)90362-4 · Cited by 1,217
van Dongen, J., Macintyre, E., Gabert, J., Delabesse, E., Rossi, V, Saglio, G., Gottardi, E., Rambaldi, A., Dotti, G., Griesinger, F., et al. (1999) · Leukemia · doi:10.1038/sj.leu.2401592 · Cited by 1,169
Cancer stem cells: an evolving concept
Nguyen, L. V., Vanner, R., Dirks, P., & Eaves, C. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3184 · Cited by 1,171
The Chromosomal Basis of Human Neoplasia
Yunis, J. J. (1983) · Science · doi:10.1126/science.6336310 · Cited by 1,087
MicroRNAs in Development and Disease
Sayed, D., & Abdellatif, M. (2011) · Physiological Reviews · doi:10.1152/physrev.00006.2010 · Cited by 1,078
“One of the characteristics of CML is a translocation of t(9;22) (640), which results in the production of the BCRABL fusion gene (25, 29, 135, 242).”
BackgroundAmplification of a Novel v- erb B-Related Gene in a Human Mammary Carcinoma
King, C. R., Kraus, M. H., & Aaronson, S. A. (1985) · Science · doi:10.1126/science.2992089 · Cited by 1,072
Structural organization of the bcr gene and its role in the Ph′ translocation
Heisterkamp, N., Stam, K., Groffen, J., de Klein, A., & Grosveld, G. (1985) · Nature · doi:10.1038/315758a0 · Cited by 882
Self-citationHeisterkamp, N., Stephenson, J. R., Groffen, J., Hansen, P. F., de Klein, A., Bartram, C. R., & Grosveld, G. (1983) · Nature · doi:10.1038/306239a0 · Cited by 842
Self-citationChromosome aberrations in solid tumors
Albertson, D. G., Collins, C., McCormick, F., & Gray, J. W. (2003) · Nature Genetics · doi:10.1038/ng1215 · Cited by 812
TopHat-Fusion: an algorithm for discovery of novel fusion transcripts
Kim, D., & Salzberg, S. L. (2011) · Genome Biology · doi:10.1186/gb-2011-12-8-r72 · Cited by 809
“‘Fusion’ genes formed by the breakage and re-joining of two different chromosomes have repeatedly been implicated in the development of cancer, notably the BCR/ABL1 gene fusion in chronic myeloid leukemia [7-9].”
BackgroundBartram, C. R., de Klein, A., Hagemeijer, A., van Agthoven, T., van Kessel, A. G., Bootsma, D., Grosveld, G., Ferguson-Smith, M. A., Davies, T., Stone, M., et al. (1983) · Nature · doi:10.1038/306277a0 · Cited by 747
Self-citationKawasaki, E. S., Clark, S. S., Coyne, M. Y., Smith, S. D., Champlin, R., Witte, O. N., & McCormick, F. P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.15.5698 · Cited by 709
Translation of the Philadelphia chromosome into therapy for CML
Druker, B. J. (2008) · Blood · doi:10.1182/blood-2008-07-077958 · Cited by 668
Acute leukaemia in bcr/abl transgenic mice
Heisterkamp, N., Jenster, G., ten Hoeve, J., Zovich, D., Pattengale, P. K., & Groffen, J. (1990) · Nature · doi:10.1038/344251a0 · Cited by 672
Self-citationEvolution of tumours and the impact of molecular oncology
Klein, G., & Klein, E. (1985) · Nature · doi:10.1038/315190a0 · Cited by 661
TRKing Down an Old Oncogene in a New Era of Targeted Therapy
Vaishnavi, A., Le, A. T., & Doebele, R. C. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0765 · Cited by 642
Theo Cuypers, H., Selten, G., Quint, W., Zijlstra, M., Maandag, E. R., Boelens, W., van Wezenbeek, P., Melief, C., & Berns, A. (1984) · Cell · doi:10.1016/0092-8674(84)90309-x · Cited by 639
Molecular Analysis of Acute Promyelocytic Leukemia Breakpoint Cluster Region on Chromosome 17
Borrow, J., Goddard, A. D., Sheer, D., & Solomon, E. (1990) · Science · doi:10.1126/science.2218500 · Cited by 632
Mechanism of met oncogene activation
Park, M., Dean, M., Cooper, C. S., Schmidt, M., O'Brien, S. J., Blair, D. G., & Vande Woude, G. F. (1986) · Cell · doi:10.1016/0092-8674(86)90564-7 · Cited by 560
Park, M., Dean, M., Kaul, K., Braun, M. J., Gonda, M. A., & Vande Woude, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.18.6379 · Cited by 561
Rabbitts, T. H., Forster, A., Larson, R., & Nathan, P. (1993) · Nature Genetics · doi:10.1038/ng0693-175 · Cited by 554
Bhatia, R., Holtz, M., Niu, N., Gray, R., Snyder, D. S., Sawyers, C. L., Arber, D. A., Slovak, M. L., & Forman, S. J. (2003) · Blood · doi:10.1182/blood-2002-09-2780 · Cited by 547
PML targeting eradicates quiescent leukaemia-initiating cells
Ito, K., Bernardi, R., Morotti, A., Matsuoka, S., Saglio, G., Ikeda, Y., Rosenblatt, J., Avigan, D. E., Teruya-Feldstein, J., & Pandolfi, P. P. (2008) · Nature · doi:10.1038/nature07016 · Cited by 538
Smart drugs: Tyrosine kinase inhibitors in cancer therapy
Shawver, L. K., Slamon, D., & Ullrich, A. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00039-9 · Cited by 522
Clonal genomic alterations in glioma malignancy stages.
Cd, J., Carlbom, E., Dumanski, J. P., Hansen, M., Nordenskjöld, M., Collins, V. P., & Cavenee, W. K. (1988) · PubMed · Cited by 512
Attisano, L., Wrana, J. L., Cheifetz, S., & Massague, J. (1992) · Cell · doi:10.1016/0092-8674(92)90209-u · Cited by 474
Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus.
Rapp, U. R., Goldsborough, M. D., Mark, G. E., Bonner, T. I., Groffen, J., Reynolds, F. H., & Stephenson, J. R. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.14.4218 · Cited by 483
Self-citationThe Approaching Era of the Tumor Suppressor Genes
Klein, G. (1987) · Science · doi:10.1126/science.3317834 · Cited by 461
Translocation, breakage and truncated transcripts of c-myc oncogene in murine plasmacytomas
Stanton, L. W., Watt, R., & Marcu, K. B. (1983) · Nature · doi:10.1038/303401a0 · Cited by 481
Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases
Apsel, B., Blair, J. A., Gonzalez, B., Nazif, T. M., Feldman, M. E., Aizenstein, B., Hoffman, R., Williams, R. L., Shokat, K. M., & Knight, Z. A. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.117 · Cited by 440
A common molecular basis for rearrangement disorders on chromosome 22q11
Edelmann, L. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1157 · Cited by 453
Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene
Shtivelman, E., Lifshitz, B., Gale, R. P., Roe, B. A., & Canaani, E. (1986) · Cell · doi:10.1016/0092-8674(86)90450-2 · Cited by 464
Schwab, M., Alitalo, K., Varmus, H. E., Bishop, J. M., & George, D. (1983) · Nature · doi:10.1038/303497a0 · Cited by 458
Hall, A., Marshall, C. J., Spurr, N. K., & Weiss, R. A. (1983) · Nature · doi:10.1038/303396a0 · Cited by 442
Self-citationFusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia
Graux, C., Cools, J., Melotte, C., Quentmeier, H., Ferrando, A., Levine, R., Vermeesch, J. R., Stul, M., Dutta, B., Boeckx, N., et al. (2004) · Nature Genetics · doi:10.1038/ng1425 · Cited by 433
“1 M 52 134 96 Cortical 46,XY,del(12)(p13) [4]/ 46,XY [1] +/+ Amp + TLX1 CR, early relapse 7 2 M 3 162 95 Cortical 46,XY [12] / Amp + TLX1 CR 57+ 3 M 23 81 92 Cortical 48,XY,t(3;11)(p12;p15), t(7;10)(q35;q24), t(8;10) (q21;q21),+11,+12 [5] / 46,XY [4] /+ Amp + TLX1 CR, alloBMT, toxic death 10”
Self-citationWhite, D. L., Saunders, V. A., Dang, P., Engler, J., Zannettino, A. C. W., Cambareri, A. C., Quinn, S. R., Manley, P. W., & Hughes, T. P. (2006) · Blood · doi:10.1182/blood-2005-11-4687 · Cited by 435
McWhirter, J. R., Galasso, D. L., & Wang, J. Y. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7587 · Cited by 420
The BCR-ABL Story: Bench to Bedside and Back
Wong, S., & Witte, O. N. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104753 · Cited by 399
Drebin, J. A., Link, V. C., Stern, D. F., Weinberg, R. A., & Greene, M. I. (1985) · Cell · doi:10.1016/s0092-8674(85)80050-7 · Cited by 400
von Lindern, M., van Baal, S., Wiegant, J., Raap, A., Hagemeijer, A., & Grosveld, G. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.8.3346 · Cited by 387
Self-citationHermans, A., Heisterkamp, N., von Lindern, M., van Baal, S., Meijer, D., van der Plas, D., Wiedemann, L. M., Groffen, J., Bootsma, D., & Grosveld, G. (1987) · Cell · doi:10.1016/0092-8674(87)90007-9 · Cited by 387
Self-citationLow-Copy Repeats Mediate the Common 3-Mb Deletion in Patients with Velo-cardio-facial Syndrome
Edelmann, L., Pandita, R. K., & Morrow, B. E. (1999) · The American Journal of Human Genetics · doi:10.1086/302343 · Cited by 376
“The BCR gene is of particular interest because a BCR/ABL fusion gene product results from a t(9;22) translocation implicated in acute lymphocytic leukemia and chronic myelogenous leukemia (MIM 151410) (de Klein et al. 1982; Shtivelman et al. 1985).”
BackgroundCárcamo, J., Weis, F. M. B., Ventura, F., Wieser, R., Wrana, J. L., Attisano, L., & Massagué, J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.3810-3821.1994 · Cited by 71
Structure and polymorphism of human telomere-associated DNA
Brown, W. R. A., MacKinnon, P. J., Villasanté, A., Spurr, N., Buckle, V. J., & Dobson, M. J. (1990) · Cell · doi:10.1016/0092-8674(90)90293-n · Cited by 375
Self-citationYokota, J., Tsunetsugu-Yokota, Y., Battifora, H., Le Fevre, C., & Cline, M. J. (1986) · Science · doi:10.1126/science.3941898 · Cited by 374
Imatinib as a Paradigm of Targeted Therapies
(2004) · Advances in Cancer Research · doi:10.1016/s0065-230x(04)91001-9 · Cited by 370
Detection of bcr - abl Fusion in Chronic Myelogeneous Leukemia by in Situ Hybridization
Tkachuk, D. C., Westbrook, C. A., Andreeff, M., Donlon, T. A., Cleary, M. L., Suryanarayan, K., Homge, M., Redner, A., Gray, J., & Pinkel, D. (1990) · Science · doi:10.1126/science.2237408 · Cited by 372
WILLIAMS, D., THOMASLOOK, A., MELVIN, S., ROBERSON, P., DAHL, G., FLAKE, T., & STASS, S. (1984) · Cell · doi:10.1016/0092-8674(84)90078-3 · Cited by 357
Specific chromosomal abnormalities in malignant human gliomas.
Sh, B., Mark, J., Burger, P. C., Ms, M., Bullard, D. E., Lh, M., & Bigner, D. D. (1988) · PubMed · Cited by 340
Activation Of Cellular Oncogenes in Hemopoietic Cells by Chromosome Translocation
(1986) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60200-6 · Cited by 343
Leukocyte interferon-induced myeloid cytoreduction in chronic myelogenous leukemia
Talpaz, M., McCredie, K., Mavligit, G., & Gutterman, J. (1983) · Blood · doi:10.1182/blood.v62.3.689.689 · Cited by 336
Thakker, R. V., Bouloux, P., Wooding, C., Chotai, K., Broad, P. M., Spurr, N. K., Besser, G. M., & O'Riordan, J. L. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198907273210403 · Cited by 334
Self-citationMolecular Genetics of Lung Cancer
Sekido, Y., Fong, K. M., & Minna, J. D. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152202 · Cited by 313
Unique Forms of the abl Tyrosine Kinase Distinguish Ph 1 -Positive CML from Ph 1 -Positive ALL
Clark, S. S., McLaughlin, J., Crist, W. M., Champlin, R., & Witte, O. N. (1987) · Science · doi:10.1126/science.3541203 · Cited by 320
Identification of fusion genes in breast cancer by paired-end RNA-sequencing
Edgren, H., Murumagi, A., Kangaspeska, S., Nicorici, D., Hongisto, V., Kleivi, K., Rye, I. H., Nyberg, S., Wolf, M., Borresen-Dale, A.-L., et al. (2011) · Genome Biology · doi:10.1186/gb-2011-12-1-r6 · Cited by 316
Onco gen: Human oncogene locations and chromosome aberrations
Rowley, J. D. (1983) · Nature · doi:10.1038/301290a0 · Cited by 307
Fredericks, W. J., Galili, N., Mukhopadhyay, S., Rovera, G., Bennicelli, J., Barr, F. G., & Rauscher, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1522 · Cited by 305
Liu, B. A., Jablonowski, K., Raina, M., Arcé, M., Pawson, T., & Nash, P. D. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.001 · Cited by 294
Chakravarty, D., Johnson, A., Sklar, J., Lindeman, N. I., Moore, K., Ganesan, S., Lovly, C. M., Perlmutter, J., Gray, S. W., Hwang, J., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02767 · Cited by 266
Baarends, W. M., Helmond, M. J. L. V., Post, M., Schoot, P. J. C. M. V. D., Hoogerbrugge, J. W., Winter, J. P. D., Uilenbroek, J. T. J., Karels, B., Wilming, L. G., Meijers, J. H. C., et al. (1994) · Development · doi:10.1242/dev.120.1.189 · Cited by 290
McWhirter, J. R., & Wang, J. Y. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.3.1553 · Cited by 276
“Chronic myelogenous leukemia (CML) and one type of acute lymphoblastic leukemia (ALL) are characterized by the clonal expansion of a hematopoietic stem cell containing a reciprocal translocation between chromosomes 9 and 22 (6, 11, 30).”
BackgroundPerspectives on the development of a molecularly targeted agent
Druker, B. J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00025-9 · Cited by 273
“The molecular consequence of this translocation is the replacement of the first exon of c-abl with sequences from the bcr gene resulting in a bcr-abl fusion gene and mRNA (de Klein et al., 1982; Groffen et al., 1984; Heisterkamp et al., 1983; Shtivelman et al., 1985).”
BackgroundGerm-Line Transmission of a c- abl Mutation Produced by Targeted Gene Disruption in ES Cells
Schwartzberg, P. L., Goff, S. P., & Robertson, E. J. (1989) · Science · doi:10.1126/science.2554496 · Cited by 277
Chromosome translocations: dangerous liaisons revisited
Rowley, J. D. (2001) · Nature Reviews Cancer · doi:10.1038/35106108 · Cited by 274
A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia
Kurzrock, R., Shtalrid, M., Romero, P., Kloetzer, W. S., Talpas, M., Trujillo, J. M., Blick, M., Beran, M., & Gutterman, J. U. (1987) · Nature · doi:10.1038/325631a0 · Cited by 270
Chromosomal microdeletions: dissecting del22q11 syndrome
Lindsay, E. A. (2001) · Nature Reviews Genetics · doi:10.1038/35098574 · Cited by 262
Aichberger, K. J., Mayerhofer, M., Krauth, M.-T., Skvara, H., Florian, S., Sonneck, K., Akgul, C., Derdak, S., Pickl, W. F., Wacheck, V., et al. (2005) · Blood · doi:10.1182/blood-2004-02-0749 · Cited by 253
Stam, K., Heisterkamp, N., Grosveld, G., de Klein, A., Verma, R. S., Coleman, M., Dosik, H., & Groffen, J. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512053132301 · Cited by 251
Self-citationOncogene addiction as a foundational rationale for targeted anti‐cancer therapy: promises and perils
Torti, D., & Trusolino, L. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100176 · Cited by 246
“…a balanced chromosomal translocation between the long arm of chromosome 9 (9q34) and the long arm of chromosome 22 (22q11), which produces a fusion transcript between the breakpoint cluster region-(BCR) and the gene coding for the Abelson (ABL) tyrosine kinase (de Klein et al, 1982; Rowley, 1973).”
BackgroundVerfaillie, C. M., McCarthy, J. B., & McGlave, P. B. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115985 · Cited by 249
“At the molecular level, juxtaposition of 5' coding sequences of the bcr gene on chromosome 22 and 3' coding sequences of the c-abl gene on chromosome 9 (bcr/abl) occurs (2).”
BackgroundTargeting Akt in cancer for precision therapy
Hua, H., Zhang, H., Chen, J., Wang, J., Liu, J., & Jiang, Y. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01137-8 · Cited by 241
Shi, Y., Alin, K., & Goff, S. P. (1995) · Genes & Development · doi:10.1101/gad.9.21.2583 · Cited by 247
Pinilla-Ibarz, J., Cathcart, K., Korontsvit, T., Soignet, S., Bocchia, M., Caggiano, J., Lai, L., Jimenez, J., Kolitz, J., & Scheinberg, D. A. (2000) · Blood · doi:10.1182/blood.v95.5.1781.005k46_1781_1787 · Cited by 247
Malignancies After Hematopoietic Stem Cell Transplantation: Many Questions, Some Answers
Deeg, H. J., & Socié, G. (1998) · Blood · doi:10.1182/blood.v91.6.1833 · Cited by 249
Ras Farnesyltransferase: A New Therapeutic Target
Leonard, D. M. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970226l · Cited by 241
Expression of a Distinctive BCR-ABL Oncogene in Ph 1 -Positive Acute Lymphocytic Leukemia (ALL)
Clark, S. S., McLaughlin, J., Timmons, M., Pendergast, A. M., Ben-Neriah, Y., Dow, L. W., Crist, W., Rovera, G., Smith, S. D., & Witte, O. N. (1988) · Science · doi:10.1126/science.3422516 · Cited by 235
Collins, S. J., & Groudine, M. T. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.15.4813 · Cited by 237
Chromosomal Abnormalities in Cancer
Fröhling, S., & Döhner, H. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0803109 · Cited by 229
Clinical Implications of the Cancer Genome
MacConaill, L. E., & Garraway, L. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.4944 · Cited by 229
“ABL1, which had previously been identified as a viral oncogene, was ultimately identified as the critical gene activated by the 9;22 translocation.(7)”
BackgroundClinical cancer genomic profiling
Chakravarty, D., & Solit, D. B. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00338-8 · Cited by 226
Regulation of Cell Proliferation, Apoptosis, and Carcinogenesis by Activin
Chen, Y.-G., Lui, H. M., Lin, S.-L., Lee, J. M., & Ying, S.-Y. (2002) · Experimental Biology and Medicine · doi:10.1177/153537020222700201 · Cited by 226
Ou, S.-H. I., Bartlett, C. H., Mino-Kenudson, M., Cui, J., & Iafrate, A. J. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0311 · Cited by 224
Retroviral transforming genes in normal cells?
Duesberg, P. H. (1983) · Nature · doi:10.1038/304219a0 · Cited by 222
Ly, P., Brunner, S. F., Shoshani, O., Kim, D. H., Lan, W., Pyntikova, T., Flanagan, A. M., Behjati, S., Page, D. C., Campbell, P. J., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0360-8 · Cited by 224
A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistance
Gumireddy, K., Baker, S. J., Cosenza, S. C., John, P., Kang, A. D., Robell, K. A., Reddy, M. V. R., & Reddy, E. P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408283102 · Cited by 220
Cytogenetic analysis of 109 pediatric central nervous system tumors
Neumann, E., Kalousek, D. K., Norman, M. G., Steinbok, P., Cochrane, D. D., & Goddard, K. (1993) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(93)90200-6 · Cited by 220
The molecular biology of chronic myeloid leukaemia.
Melo, J. V. (1996) · PubMed · Cited by 246
BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice
Voncken, J., Kaartinen, V, Pattengale, P., Germeraad, W., Groffen, J., & Heisterkamp, N. (1995) · Blood · doi:10.1182/blood.v86.12.4603.bloodjournal86124603 · Cited by 216
“The MT-BCW ABL P210 was constructed from three segments: (1) the complete murine MT-1 promoter fused to BCR exon 1 plus a segment of 3’ intron; (2) the intron immediately preceding BCR gene exon 2 and additional BCR gene exons up to and including Mbcr exon 2 and Mbcr exon 3 with flanking introns; and ( 3 ) ABL exon 2…”
MethodSelf-citationChu, S., Xu, H., Shah, N. P., Snyder, D. S., Forman, S. J., Sawyers, C. L., & Bhatia, R. (2005) · Blood · doi:10.1182/blood-2004-03-1114 · Cited by 209
Metadata
- Authors
- Klein, A. D., Kessel, A. G. V., Grosveld, G., Bartram, C. R., Hagemeijer, A., Bootsma, D., Spurr, N. K., Heisterkamp, N., Groffen, J., & Stephenson, J. R.
- Affiliations
- Erasmus University Rotterdam (NL)
- National Cancer Institute (US)
- Venue
- Nature
- Published
- 1982-12
- Volume
- 300
- Issue
- 5894
- Pages
- 765-767
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2060833726
- Cited by
- 1,378
- References
- 27
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 17 · 2023: 12 · 2022: 25 · 2021: 17 · 2020: 18 · 2019: 15 · 2018: 23 · 2017: 28 · 2016: 24 · 2015: 33 · 2014: 16 · 2013: 26 · 2012: 33
- FWCI
- 50.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- Philadelphia chromosome, chromosome 9, chromosome 22, reciprocal translocation, cellular oncogenes, somatic cell hybrids
- MeSH terms
- Chromosomes, Human, 21-22 and Y, Chromosomes, Human, 6-12 and X, DNA, Neoplasm, Gene Expression Regulation, Humans, Leukemia, Myeloid, Oncogenes, Translocation, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.